aTyr Pharma
ATYR
5,31 €
Share price
5.66%
Change (1 day)
171.21%
Change (1 year)
Categories
aTyr Pharma (ATYR) - Net assets
Net assets on the balance sheet as of March 2025 : €64.58 Million
According to aTyr Pharma's latest financial reports the company has €64.58 Million in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
aTyr Pharma - Net assets on balance sheet (from 2014 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $€67.1 M | -18% |
| 2023-12-31 | $€81.83 M | 23.15% |
| 2022-12-31 | $€66.45 M | -31.03% |
| 2021-12-31 | $€96.35 M | 276.44% |
| 2020-12-31 | $€25.59 M | 36.38% |
| 2019-12-31 | $€18.76 M | -36.19% |
| 2018-12-31 | $€29.41 M | -45.06% |
| 2017-12-31 | $€53.54 M | -10.32% |
| 2016-12-31 | $€59.7 M | -43.26% |
| 2015-12-31 | $€0.10 B | -240.61% |
| 2014-12-31 | $-€74.84 Million | 56.38% |
| 2013-12-31 | $-€47.86 Million |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Veracyte VCYT | €1.03 B | 1,496.19% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | €14.23 B | 21,935.61% | 🇺🇸 USA |